Completed × Lenalidomide × Dermatologic × Clear all
NCT01254578 2017-09-25

Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancers

National Cancer Institute (NCI)

Phase 1 Completed
17 enrolled
NCT01183663 2016-06-03

Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)

M.D. Anderson Cancer Center

Phase 1 Completed
180 enrolled
NCT00031941 2012-03-15

CC-5013 in Treating Patients With Cancer That Has Not Responded to Previous Therapy

National Institutes of Health Clinical Center (CC)

Phase 1 Completed